Unprotected exposure to UV rays is a major risk factor for skin cancer, the most common cancer in the United States. It is estimated that one in five Americans will develop skin cancer in their ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that the U.S. Food ...

The U.S. Department of Justice's recent subpoenas and the Hsiao Declaration signal a potential redefinition of enforcement boundaries under the ...

Health care professionals can have a powerful impact on labeling requirements for drugs by formally petitioning the FDA for ...

A top FDA official has proposed broad changes to the review and approval process for vaccines, citing a new internal review linking the deaths of 10 children to COVID-19 vaccines. In an internal memo ...

The FDA’s removal of the black box warning from hormone therapy products acknowledges decades of evolving evidence and could help millions of women seek relief safely. The U.S. Food and Drug ...

Studies in the early 2000s claimed there were major risks associated with HRT. The Food and Drug Administration said Monday it will remove the "black box" warning from hormone replacement therapy (HRT ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...

The MarketWatch News Department was not involved in the creation of this content. DUBLIN and BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company ...

Sotatercept-csrk is approved for improving exercise capacity and reducing clinical worsening in PAH patients, following FDA label expansion. The ZENITH trial showed a 76% reduction in major morbidity ...